Triple-negative breast cancer (TNBC), a subtype that does not overexpress estrogen receptor, progesterone receptor or human epidermal growth factor receptor 2 (HER2) gene (ER−/PR−/HER2−), is a minimally methylated cancer. Here, ERBB2 is linked to triple-negative breast carcinoma.